Cover Image
Market Research Report
Product code 
1093036

Asia Pacific Sepsis Diagnostics Market Size, Share & Industry Trends Analysis Report By Method, By Test Type, By Pathogen, By Product, By End-User, By Technology, By Country and Growth Forecast, 2022 - 2028

Published: | KBV Research | 141 Pages | Delivery time: 1-2 business days

Price

Back to Top
Asia Pacific Sepsis Diagnostics Market Size, Share & Industry Trends Analysis Report By Method, By Test Type, By Pathogen, By Product, By End-User, By Technology, By Country and Growth Forecast, 2022 - 2028
Published: April 29, 2022
KBV Research
Content info: 141 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Asia Pacific Sepsis Diagnostics Market would witness market growth of 9.3% CAGR during the forecast period (2022-2028).

Current sepsis diagnosis approaches are based on non-specific physiological and clinical parameters, making it difficult to differentiate sepsis from a systemic inflammatory response induced by normal inflammation. The preliminary test for infection, coagulation and reduced oxygen availability is a blood test, Urine wound secretions, and respiratory secretions are among the other tests that are performed. If these tests fail to diagnose sepsis and identify the site of inflammation, X-rays, Magnetic Resonance Imaging, Computerized Tomography, and Ultrasound are performed.

The rising number of hospital-acquired infections (HAIs) that cause sepsis, especially among the elderly, babies, and patients with chronic illnesses, is increasing the demand for sepsis diagnostics. Further, the increased prevalence of a variety of infectious disorders caused by antibiotic-resistant bacteria, including both gram-positive and gram-negative bacteria, is driving the demand for sepsis diagnostics. Furthermore, the rising healthcare sector, combined with the growing use of modern data analytics technologies and , a rise in the number of drugs approved for sepsis diagnosis, is propelling the market forward.

There are several developing countries across this region, due to which, these countries are majorly investing on the enhancement of their healthcare infrastructure. For example, china and India are observing rapid economic development and innovation in the medical system. Moreover, due to the high death rate linked with sepsis disease, the necessity for sepsis diagnostics is likely to increase. In addition, increased awareness of sepsis monitoring and diagnosis in the region's countries is likely to minimize the disease's negative effects. This is due to an increase in the demand for sepsis diagnostic treatments in countries with high rates of infectious illnesses. The expansion of the regional market is also owing to an increase in regional activities to expand access to breakthrough laboratory automation systems.

The China market dominated the Asia Pacific Sepsis Diagnostics Market by Country in 2021, and would continue to be a dominant market till 2018; thereby, achieving a market value of $69.5 million by 2028. The Japan market is experiencing a CAGR of 8.6% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 9.9% during (2022 - 2028).

Based on Method, the market is segmented into Conventional and Automated. Based on Test Type, the market is segmented into Laboratory Tests and Point-of-Care Tests. Based on Pathogen, the market is segmented into Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, and Others. Based on Product, the market is segmented into Blood Culture Media, Assays & Reagents, Instruments, and Software. Based on End-User, the market is segmented into Hospitals & specialty clinics, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes. Based on Technology, the market is segmented into Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, and Biomarkers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMerieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., DiaSorin S.p.A., Bruker Corporation, Siemens Healthineers AG, Danaher Corporation, and Quidel Corporation.

Scope of the Study

Market Segments covered in the Report:

By Method

  • Conventional
  • Automated

By Test Type

  • Laboratory Tests
  • Point-of-Care Tests

By Pathogen

  • Bacterial Sepsis
  • Fungal Sepsis
  • Viral Sepsis
  • Others

By Product

  • Blood Culture Media
  • Assays & Reagents
  • Instruments
  • Software

By End-User

  • Hospitals & specialty clinics
  • Pathology & Reference Laboratories
  • Research Laboratories & Academic Institutes

By Technology

  • Blood Culture
  • Immunoassays
  • Molecular Diagnostics
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • BioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • DiaSorin S.p.A.
  • Bruker Corporation
  • Siemens Healthineers AG
  • Danaher Corporation
  • Quidel Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Sepsis Diagnostics Market, by Method
    • 1.4.2 Asia Pacific Sepsis Diagnostics Market, by Test Type
    • 1.4.3 Asia Pacific Sepsis Diagnostics Market, by Pathogen
    • 1.4.4 Asia Pacific Sepsis Diagnostics Market, by Product
    • 1.4.5 Asia Pacific Sepsis Diagnostics Market, by End-User
    • 1.4.6 Asia Pacific Sepsis Diagnostics Market, by Technology
    • 1.4.7 Asia Pacific Sepsis Diagnostics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Approvals and Trials
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul - 2021, Dec) Leading Players

Chapter 4. Asia Pacific Sepsis Diagnostics Market by Method

  • 4.1 Asia Pacific Conventional Market by Country
  • 4.2 Asia Pacific Automated Market by Country

Chapter 5. Asia Pacific Sepsis Diagnostics Market by Test Type

  • 5.1 Asia Pacific Laboratory Tests Market by Country
  • 5.2 Asia Pacific Point-of-Care Tests Market by Country

Chapter 6. Asia Pacific Sepsis Diagnostics Market by Pathogen

  • 6.1 Asia Pacific Bacterial Sepsis Market by Country
  • 6.2 Asia Pacific Fungal Sepsis Market by Country
  • 6.3 Asia Pacific Viral Sepsis Market by Country
  • 6.4 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Sepsis Diagnostics Market by Product

  • 7.1 Asia Pacific Blood Culture Media Market by Country
  • 7.2 Asia Pacific Assays & Reagents Market by Country
  • 7.3 Asia Pacific Instruments Market by Country
  • 7.4 Asia Pacific Software Market by Country

Chapter 8. Asia Pacific Sepsis Diagnostics Market by End-User

  • 8.1 Asia Pacific Hospitals & specialty clinics Market by Country
  • 8.2 Asia Pacific Pathology & Reference Laboratories Market by Country
  • 8.3 Asia Pacific Research Laboratories & Academic Institutes Market by Country

Chapter 9. Asia Pacific Sepsis Diagnostics Market by Technology

  • 9.1 Asia Pacific Blood Culture Market by Country
  • 9.2 Asia Pacific Immunoassays Market by Country
  • 9.3 Asia Pacific Molecular Diagnostics Market by Country
  • 9.4 Asia Pacific Flow Cytometry Market by Country
  • 9.5 Asia Pacific Microfluidics Market by Country
  • 9.6 Asia Pacific Biomarkers Market by Country

Chapter 10. Asia Pacific Sepsis Diagnostics Market by Country

  • 10.1 China Sepsis Diagnostics Market
    • 10.1.1 China Sepsis Diagnostics Market by Method
    • 10.1.2 China Sepsis Diagnostics Market by Test Type
    • 10.1.3 China Sepsis Diagnostics Market by Pathogen
    • 10.1.4 China Sepsis Diagnostics Market by Product
    • 10.1.5 China Sepsis Diagnostics Market by End-User
    • 10.1.6 China Sepsis Diagnostics Market by Technology
  • 10.2 Japan Sepsis Diagnostics Market
    • 10.2.1 Japan Sepsis Diagnostics Market by Method
    • 10.2.2 Japan Sepsis Diagnostics Market by Test Type
    • 10.2.3 Japan Sepsis Diagnostics Market by Pathogen
    • 10.2.4 Japan Sepsis Diagnostics Market by Product
    • 10.2.5 Japan Sepsis Diagnostics Market by End-User
    • 10.2.6 Japan Sepsis Diagnostics Market by Technology
  • 10.3 India Sepsis Diagnostics Market
    • 10.3.1 India Sepsis Diagnostics Market by Method
    • 10.3.2 India Sepsis Diagnostics Market by Test Type
    • 10.3.3 India Sepsis Diagnostics Market by Pathogen
    • 10.3.4 India Sepsis Diagnostics Market by Product
    • 10.3.5 India Sepsis Diagnostics Market by End-User
    • 10.3.6 India Sepsis Diagnostics Market by Technology
  • 10.4 South Korea Sepsis Diagnostics Market
    • 10.4.1 South Korea Sepsis Diagnostics Market by Method
    • 10.4.2 South Korea Sepsis Diagnostics Market by Test Type
    • 10.4.3 South Korea Sepsis Diagnostics Market by Pathogen
    • 10.4.4 South Korea Sepsis Diagnostics Market by Product
    • 10.4.5 South Korea Sepsis Diagnostics Market by End-User
    • 10.4.6 South Korea Sepsis Diagnostics Market by Technology
  • 10.5 Singapore Sepsis Diagnostics Market
    • 10.5.1 Singapore Sepsis Diagnostics Market by Method
    • 10.5.2 Singapore Sepsis Diagnostics Market by Test Type
    • 10.5.3 Singapore Sepsis Diagnostics Market by Pathogen
    • 10.5.4 Singapore Sepsis Diagnostics Market by Product
    • 10.5.5 Singapore Sepsis Diagnostics Market by End-User
    • 10.5.6 Singapore Sepsis Diagnostics Market by Technology
  • 10.6 Malaysia Sepsis Diagnostics Market
    • 10.6.1 Malaysia Sepsis Diagnostics Market by Method
    • 10.6.2 Malaysia Sepsis Diagnostics Market by Test Type
    • 10.6.3 Malaysia Sepsis Diagnostics Market by Pathogen
    • 10.6.4 Malaysia Sepsis Diagnostics Market by Product
    • 10.6.5 Malaysia Sepsis Diagnostics Market by End-User
    • 10.6.6 Malaysia Sepsis Diagnostics Market by Technology
  • 10.7 Rest of Asia Pacific Sepsis Diagnostics Market
    • 10.7.1 Rest of Asia Pacific Sepsis Diagnostics Market by Method
    • 10.7.2 Rest of Asia Pacific Sepsis Diagnostics Market by Test Type
    • 10.7.3 Rest of Asia Pacific Sepsis Diagnostics Market by Pathogen
    • 10.7.4 Rest of Asia Pacific Sepsis Diagnostics Market by Product
    • 10.7.5 Rest of Asia Pacific Sepsis Diagnostics Market by End-User
    • 10.7.6 Rest of Asia Pacific Sepsis Diagnostics Market by Technology

Chapter 11. Company Profiles

  • 11.1 BioMerieux S.A.
    • 11.1.1 Company Overview
    • 11.1.2 Financial Analysis
    • 11.1.3 Segmental and Regional Analysis
    • 11.1.4 Research & Development Expenses
    • 11.1.5 Recent strategies and developments:
      • 11.1.5.1 Acquisition and Mergers:
  • 11.2 F. Hoffmann-La Roche Ltd.
    • 11.2.1 Company Overview
    • 11.2.2 Financial Analysis
    • 11.2.3 Segmental and Regional Analysis
    • 11.2.4 Research & Development Expense
    • 11.2.5 Recent strategies and developments:
      • 11.2.5.1 Partnerships, Collaborations, and Agreements:
      • 11.2.5.2 Approvals and Trials:
  • 11.3 Becton, Dickinson and Company
    • 11.3.1 Company Overview
    • 11.3.2 Financial Analysis
    • 11.3.3 Segmental and Regional Analysis
    • 11.3.4 Research & Development Expense
    • 11.3.5 Recent strategies and developments:
      • 11.3.5.1 Product Launches and Product Expansions:
  • 11.4 Abbott Laboratories
    • 11.4.1 Company Overview
    • 11.4.2 Financial Analysis
    • 11.4.3 Segmental and Regional Analysis
    • 11.4.4 Research & Development Expense
    • 11.4.5 Recent strategies and developments:
      • 11.4.5.1 Acquisition and Mergers:
  • 11.5 Thermo Fisher Scientific, Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Financial Analysis
    • 11.5.3 Segmental and Regional Analysis
    • 11.5.4 Research & Development Expense
    • 11.5.5 Recent strategies and developments:
      • 11.5.5.1 Partnerships, Collaborations, and Agreements:
      • 11.5.5.2 Approvals and Trials:
      • 11.5.5.3 Acquisition and Mergers:
    • 11.5.6 SWOT Analysis
  • 11.6 DiaSorin S.p.A. (Luminex Corporation)
    • 11.6.1 Company Overview
    • 11.6.2 Financial Analysis
    • 11.6.3 Regional Analysis
    • 11.6.4 Research & Development Expenses
    • 11.6.5 Recent strategies and developments:
      • 11.6.5.1 Acquisitions and Mergers:
  • 11.7 Bruker Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Financial Analysis
    • 11.7.3 Segmental and Regional Analysis
    • 11.7.4 Research & Development Expense
    • 11.7.5 Recent strategies and developments:
      • 11.7.5.1 Product Launches and Product Expansions:
      • 11.7.5.2 Acquisition and Mergers:
  • 11.8 Siemens Healthineers AG (Siemens AG)
    • 11.8.1 Company Overview
    • 11.8.2 Financial Analysis
    • 11.8.3 Segmental and Regional Analysis
    • 11.8.4 Research & Development Expenses
    • 11.8.5 Recent strategies and developments:
      • 11.8.5.1 Partnerships, Collaborations, and Agreements:
      • 11.8.5.2 Acquisition and Mergers:
  • 11.9 Danaher Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Financial Analysis
    • 11.9.3 Segmental and Regional Analysis
    • 11.9.4 Research & Development Expense
  • 11.10. Quidel Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Financial Analysis
    • 11.10.3 Regional Analysis
    • 11.10.4 Research & Development Expense
    • 11.10.5 Recent strategies and developments:
      • 11.10.5.1 Acquisition and Mergers:

LIST OF TABLES

  • TABLE 1 Asia Pacific Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 2 Asia Pacific Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements - Sepsis Diagnostics Market
  • TABLE 4 Product Launches And Product Expansions - Sepsis Diagnostics Market
  • TABLE 5 Acquisition and Mergers - Sepsis Diagnostics Market
  • TABLE 6 Approvals and Trials - Sepsis Diagnostics Market
  • TABLE 7 Asia Pacific Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 8 Asia Pacific Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 9 Asia Pacific Conventional Market by Country, 2018 - 2021, USD Million
  • TABLE 10 Asia Pacific Conventional Market by Country, 2022 - 2028, USD Million
  • TABLE 11 Asia Pacific Automated Market by Country, 2018 - 2021, USD Million
  • TABLE 12 Asia Pacific Automated Market by Country, 2022 - 2028, USD Million
  • TABLE 13 Asia Pacific Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 14 Asia Pacific Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 15 Asia Pacific Laboratory Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 16 Asia Pacific Laboratory Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 17 Asia Pacific Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 18 Asia Pacific Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 19 Asia Pacific Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 20 Asia Pacific Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 21 Asia Pacific Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 22 Asia Pacific Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 23 Asia Pacific Fungal Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 24 Asia Pacific Fungal Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 25 Asia Pacific Viral Sepsis Market by Country, 2018 - 2021, USD Million
  • TABLE 26 Asia Pacific Viral Sepsis Market by Country, 2022 - 2028, USD Million
  • TABLE 27 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 28 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 29 Asia Pacific Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 30 Asia Pacific Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 31 Asia Pacific Blood Culture Media Market by Country, 2018 - 2021, USD Million
  • TABLE 32 Asia Pacific Blood Culture Media Market by Country, 2022 - 2028, USD Million
  • TABLE 33 Asia Pacific Assays & Reagents Market by Country, 2018 - 2021, USD Million
  • TABLE 34 Asia Pacific Assays & Reagents Market by Country, 2022 - 2028, USD Million
  • TABLE 35 Asia Pacific Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 36 Asia Pacific Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 37 Asia Pacific Software Market by Country, 2018 - 2021, USD Million
  • TABLE 38 Asia Pacific Software Market by Country, 2022 - 2028, USD Million
  • TABLE 39 Asia Pacific Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 40 Asia Pacific Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 41 Asia Pacific Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 42 Asia Pacific Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 43 Asia Pacific Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
  • TABLE 44 Asia Pacific Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
  • TABLE 45 Asia Pacific Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 46 Asia Pacific Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 47 Asia Pacific Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 48 Asia Pacific Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 49 Asia Pacific Blood Culture Market by Country, 2018 - 2021, USD Million
  • TABLE 50 Asia Pacific Blood Culture Market by Country, 2022 - 2028, USD Million
  • TABLE 51 Asia Pacific Immunoassays Market by Country, 2018 - 2021, USD Million
  • TABLE 52 Asia Pacific Immunoassays Market by Country, 2022 - 2028, USD Million
  • TABLE 53 Asia Pacific Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 54 Asia Pacific Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 55 Asia Pacific Flow Cytometry Market by Country, 2018 - 2021, USD Million
  • TABLE 56 Asia Pacific Flow Cytometry Market by Country, 2022 - 2028, USD Million
  • TABLE 57 Asia Pacific Microfluidics Market by Country, 2018 - 2021, USD Million
  • TABLE 58 Asia Pacific Microfluidics Market by Country, 2022 - 2028, USD Million
  • TABLE 59 Asia Pacific Biomarkers Market by Country, 2018 - 2021, USD Million
  • TABLE 60 Asia Pacific Biomarkers Market by Country, 2022 - 2028, USD Million
  • TABLE 61 Asia Pacific Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 62 Asia Pacific Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 63 China Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 64 China Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 65 China Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 66 China Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 67 China Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 68 China Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 69 China Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 70 China Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 71 China Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 72 China Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 73 China Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 74 China Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 75 China Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 76 China Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 77 Japan Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 78 Japan Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 79 Japan Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 80 Japan Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 81 Japan Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 82 Japan Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 83 Japan Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 84 Japan Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 85 Japan Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 86 Japan Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 87 Japan Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 88 Japan Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 89 Japan Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 90 Japan Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 91 India Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 92 India Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 93 India Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 94 India Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 95 India Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 96 India Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 97 India Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 98 India Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 99 India Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 100 India Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 101 India Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 102 India Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 103 India Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 104 India Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 105 South Korea Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 106 South Korea Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 107 South Korea Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 108 South Korea Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 109 South Korea Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 110 South Korea Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 111 South Korea Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 112 South Korea Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 113 South Korea Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 114 South Korea Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 115 South Korea Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 116 South Korea Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 117 South Korea Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 118 South Korea Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 119 Singapore Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 120 Singapore Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 121 Singapore Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 122 Singapore Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 123 Singapore Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 124 Singapore Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 125 Singapore Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 126 Singapore Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 127 Singapore Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 128 Singapore Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 129 Singapore Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 130 Singapore Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 131 Singapore Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 132 Singapore Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 133 Malaysia Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 134 Malaysia Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 135 Malaysia Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 136 Malaysia Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 137 Malaysia Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 138 Malaysia Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 139 Malaysia Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 140 Malaysia Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 141 Malaysia Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 142 Malaysia Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 143 Malaysia Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 144 Malaysia Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 145 Malaysia Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 146 Malaysia Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 147 Rest of Asia Pacific Sepsis Diagnostics Market, 2018 - 2021, USD Million
  • TABLE 148 Rest of Asia Pacific Sepsis Diagnostics Market, 2022 - 2028, USD Million
  • TABLE 149 Rest of Asia Pacific Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
  • TABLE 150 Rest of Asia Pacific Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
  • TABLE 151 Rest of Asia Pacific Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
  • TABLE 152 Rest of Asia Pacific Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
  • TABLE 153 Rest of Asia Pacific Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
  • TABLE 154 Rest of Asia Pacific Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
  • TABLE 155 Rest of Asia Pacific Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
  • TABLE 156 Rest of Asia Pacific Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
  • TABLE 157 Rest of Asia Pacific Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
  • TABLE 158 Rest of Asia Pacific Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
  • TABLE 159 Rest of Asia Pacific Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
  • TABLE 160 Rest of Asia Pacific Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
  • TABLE 161 Key information - BioMerieux S.A.
  • TABLE 162 KEY INFORMATION - F. HOFFMANN-LA ROCHE LTD.
  • TABLE 163 Key information - Becton, Dickinson and Company
  • TABLE 164 Key Information - Abbott Laboratories
  • TABLE 165 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 166 Key Information - DiaSorin S.p.A.
  • TABLE 167 Key Information - Bruker Corporation
  • TABLE 168 Key Information - Siemens Healthineers AG
  • TABLE 169 Key Information - Danaher Corporation
  • TABLE 170 key information - Quidel Corporation

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul - 2021, Dec) Leading Players
  • FIG 5 Recent strategies and developments: Thermo Fisher Scientific, Inc.
  • FIG 6 Swot analysis: thermo fisher scientific, inc.
  • FIG 7 Recent strategies and developments: Bruker Corporation